Search Results

You are looking at 21 - 30 of 886 items for :

  • "risk factor" x
  • Refine by Access: All x
Clear All
Full access

Factors Associated With False-Positive Recalls in Mammography Screening

Xinhe Mao, Wei He, Keith Humphreys, Mikael Eriksson, Natalie Holowko, Fredrik Strand, Per Hall, and Kamila Czene

between breast cancer risk factors and false-positive recalls may help reduce their occurrence. Previous studies have found that high breast density is associated with false-positive recalls. 11 – 13 However, no study thus far has investigated the

Full access

Risk Assessment and Prophylaxis for VTE in Cancer Patients

Alok A. Khorana ; (4) view/print certificate. Release date: July 5, 2011; Expiration date: July 5, 2012 Learning Objectives Upon completion of this activity, participants will be able to: Describe clinical risk factors for VTE in cancer, based on a review Describe

Full access

Contemporary Radiation Therapy in Combined Modality Therapy for Hodgkin Lymphoma

Amol K. Narang and Stephanie A. Terezakis

considered a standard regimen, with a higher number of chemotherapy cycles and/or radiation dose depending on number of risk factors, initial bulk, and response to treatment. Table 1 Definitions of Unfavorable Risk Factors by Specific Cooperative

Full access

Determining Chemotherapy Tolerance in Older Patients With Cancer

Jerome Kim and Arti Hurria

such as diabetes mellitus are associated with an increased risk of mortality in older adults with cancer, 27 , 28 whereas organ dysfunction such as renal insufficiency is a risk factor for chemotherapy toxicity. 7 , 8 Medications: Close to one

Full access

Late Cardiovascular Toxicity Following Chemotherapy for Germ Cell Tumors

Darren R. Feldman, Wendy L. Schaffer, and Richard M. Steingart

. 15 – 18 For example, higher rates of digital ischemia were identified in patients treated with cisplatin compared with those who were not (41% vs. 21%). 14 The cumulative dose of chemotherapy and the prevalence of conventional risk factors for

Full access

CLO23-052: Risk Factors and Prognosis of Stroke in Gynecologic Cancer

Ji Young Kwon, Jeong Min Song, Young Shin Chung, Kwang-Beom Lee, and Jong-Min Lee

This is a retrospective cohort study of cervical, ovarian, and endometrial cancer patients to investigate the risk factors and prognosis of stroke. Patients who experienced stroke around the time of cancer diagnosis and treatment were categorized

Full access

HSR22-170: Risk Factors for 30-Days Readmission in Pancreatic Cancer With Hospice

Paramveer Singh, Jasmeet Kaur, Tanvir Mir, Yaqub Nadeem, Marukh Khalid, and Rafiullah Khan

risk factors are associated with hospice patients' readmissions. This study aims to identify predictors of 30-day readmission and incidence of in-hospital mortality in hospice patients with PAC. Methods : A retrospective study of a nationally

Full access

Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma

James J. Harding, Ghaith Abu-Zeinah, Joanne F. Chou, Dwight Hall Owen, Michele Ly, Maeve Aine Lowery, Marinela Capanu, Richard Do, Nancy E. Kemeny, Eileen M. O'Reilly, Leonard B. Saltz, and Ghassan K. Abou-Alfa

's test was used to compare the cumulative incidence functions by covariates of interest including age, sex, race, treatment era, HCC etiologic risk factor, Child-Pugh score, AFP level, and median calcium and ALP levels. Among patients who presented with

Full access

An Update on the Role of Interim Restaging FDG-PET in Patients With Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma

Craig H. Moskowitz, Andrew Zelenetz, and Heiko Schoder

stages II, III, or IV disease and 1 to 3 risk factors according to age-adjusted International Prognostic Index score. After induction therapy with 4 cycles of R-CHOP-14, all patients underwent FDG-PET. Patients who had negative FDG-PET results then

Full access

CLO21-016: Incidence, Risk Factors, and Prognostic Implications of Peri-Transplant Orthostatic Hypotension in Patients With Multiple Myeloma

Matthew Ho, Maria Moscvin, Soon Khai Low, Sara Close, Robert Schlossman, Jacob Laubach, Brett Glotzbecker, Paul Richardson, and Giada Bianchi

to severe dehydration as defined by weight loss ≥ 5% body weight, suggesting OH could not be simply be explained by volume depletion. Multivariable analysis revealed three risk factors (white race, gabapentin, antihypertensives) and two protective